147 related articles for article (PubMed ID: 36346281)
1. Novel Use of Intranasal Dexmedetomidine for Refractory Irritability in Pediatric Home Care.
Bartoletta KM; Collura CA; Thorvilson MJ
J Palliat Med; 2023 Apr; 26(4):596-598. PubMed ID: 36346281
[No Abstract] [Full Text] [Related]
2. Dexmedetomidine at Home for Intractable Dystonia and Insomnia in Children With Special Needs: A Case Series.
De Zen L; Divisic A; Molinaro G; Solidoro S; Barbi E
J Pain Symptom Manage; 2023 Dec; 66(6):e653-e657. PubMed ID: 37544550
[TBL] [Abstract][Full Text] [Related]
3. Intranasal dexmedetomidine: Procedural sedation in palliative care: A case report.
Ferguson L; Wilson M
Palliat Med; 2021 Sep; 35(8):1625-1628. PubMed ID: 34080458
[TBL] [Abstract][Full Text] [Related]
4. The Use of Dexmedetomidine in Pediatric Palliative Care: A Preliminary Study.
Burns J; Jackson K; Sheehy KA; Finkel JC; Quezado ZM
J Palliat Med; 2017 Jul; 20(7):779-783. PubMed ID: 28186850
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine: current role in anesthesia and intensive care.
Afonso J; Reis F
Rev Bras Anestesiol; 2012; 62(1):118-33. PubMed ID: 22248773
[TBL] [Abstract][Full Text] [Related]
6. What Is the Role of Dexmedetomidine in Modern Anesthesia and Critical Care?
Chima AM; Mahmoud MA; Narayanasamy S
Adv Anesth; 2022 Dec; 40(1):111-130. PubMed ID: 36333042
[TBL] [Abstract][Full Text] [Related]
7. Intranasal Low-Dose Dexmedetomidine Reduces Postoperative Opioid Requirement in Patients Undergoing Hip Arthroplasty Under General Anesthesia.
Uusalo P; Jätinvuori H; Löyttyniemi E; Kosola J; Saari TI
J Arthroplasty; 2019 Apr; 34(4):686-692.e2. PubMed ID: 30733071
[TBL] [Abstract][Full Text] [Related]
8. Home Intranasal Dexmedetomidine for Refractory Dystonia in Pediatric Palliative Care.
De Zen L; Della Paolera S; Del Rizzo I; Taucar V; Skabar A; Barbi E
J Pain Symptom Manage; 2020 Jun; 59(6):e3-e5. PubMed ID: 32145338
[No Abstract] [Full Text] [Related]
9. Pain management following myringotomy and tube placement: intranasal dexmedetomidine versus intranasal fentanyl.
Dewhirst E; Fedel G; Raman V; Rice J; Barry N; Jatana KR; Elmaraghy C; Merz M; Tobias JD
Int J Pediatr Otorhinolaryngol; 2014 Jul; 78(7):1090-4. PubMed ID: 24814231
[TBL] [Abstract][Full Text] [Related]
10. Intranasal Dexmedetomidine for Pain Management in Older Patients: A Cross-Over, Randomized, Double-Blinded, Active-Controlled Trial.
Dieudonné Rahm N; Zaccaria I; Gil Wey B; Pautex S; Habre W; Elia N
Drugs Aging; 2023 Jun; 40(6):527-538. PubMed ID: 37170043
[TBL] [Abstract][Full Text] [Related]
11. Best Evidence-Based Dosing Recommendations for Dexmedetomidine for Premedication and Procedural Sedation in Pediatrics: Outcome of a Risk-Benefit Analysis By the Dutch Pediatric Formulary.
Freriksen JJM; van der Zanden TM; Holsappel IGA; Molenbuur B; de Wildt SN
Paediatr Drugs; 2022 May; 24(3):247-257. PubMed ID: 35344192
[TBL] [Abstract][Full Text] [Related]
12. The sedative effects and the attenuation of cardiovascular and arousal responses during anesthesia induction and intubation in pediatric patients: a randomized comparison between two different doses of preoperative intranasal dexmedetomidine.
Wang SS; Zhang MZ; Sun Y; Wu C; Xu WY; Bai J; Cai MH; Lin L
Paediatr Anaesth; 2014 Mar; 24(3):275-81. PubMed ID: 24224515
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine: a review of its use for the management of pain, agitation, and delirium in the intensive care unit.
Anger KE
Curr Pharm Des; 2013; 19(22):4003-13. PubMed ID: 23228319
[TBL] [Abstract][Full Text] [Related]
14. Intranasal dexmedetomidine and rectal ketamine for young children undergoing burn wound procedures.
Frestadius A; Grehn F; Kildal M; Huss F; Fredén F
Burns; 2022 Sep; 48(6):1445-1451. PubMed ID: 34895793
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine: A Novel Strategy for Patients with Intractable Pain, Opioid-Induced Hyperalgesia, or Delirium at the End of Life.
Hofherr ML; Abrahm JL; Rickerson E
J Palliat Med; 2020 Nov; 23(11):1515-1517. PubMed ID: 31944877
[TBL] [Abstract][Full Text] [Related]
16. Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine.
Weerink MAS; Struys MMRF; Hannivoort LN; Barends CRM; Absalom AR; Colin P
Clin Pharmacokinet; 2017 Aug; 56(8):893-913. PubMed ID: 28105598
[TBL] [Abstract][Full Text] [Related]
17. Combined intranasal fentanyl and dexmedetomidine plus inhaled nitrous oxide sedation in children needing myringotomy and ventilation tube insertion with a specific handheld device.
Trombetta A; Cossovel F; Grasso DL; Barbi E
Int J Pediatr Otorhinolaryngol; 2020 Sep; 136():110221. PubMed ID: 32797807
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation.
Hoy SM; Keating GM
Drugs; 2011 Jul; 71(11):1481-501. PubMed ID: 21812509
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, crossover assessment of the sedative and analgesic effects of intranasal dexmedetomidine.
Yuen VM; Irwin MG; Hui TW; Yuen MK; Lee LH
Anesth Analg; 2007 Aug; 105(2):374-80. PubMed ID: 17646493
[TBL] [Abstract][Full Text] [Related]
20. Analysis of 17 948 pediatric patients undergoing procedural sedation with a combination of intranasal dexmedetomidine and ketamine.
Yang F; Liu Y; Yu Q; Li S; Zhang J; Sun M; Liu L; Lei Y; Tian Q; Liu H; Tu S
Paediatr Anaesth; 2019 Jan; 29(1):85-91. PubMed ID: 30484930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]